Vir Biotechnology (VIR) Accumulated Depreciation & Amortization (2018 - 2026)

Vir Biotechnology's Accumulated Depreciation & Amortization history runs 9 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation & Amortization fell 1.95% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (down 1.95% YoY), while the FY2025 annual figure was $11.7 million, down 19.77% from the prior year.
• Accumulated Depreciation & Amortization came in at $2.8 million for Q1 2026 at Vir Biotechnology, down from $11.7 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $19.5 million in Q4 2023 to a low of $1.6 million in Q3 2022.
• A 5-year average of $8.8 million and a median of $8.8 million in 2024 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization plunged 87.79% in 2022 and jumped 835.75% in 2023, its largest moves.
• Vir Biotechnology's Accumulated Depreciation & Amortization stood at $6.8 million in 2022, then soared by 186.76% to $19.5 million in 2023, then declined by 25.15% to $14.6 million in 2024, then fell by 19.77% to $11.7 million in 2025, then plunged by 75.93% to $2.8 million in 2026.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $2.8 million, $11.7 million, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison